Results 101 to 110 of about 32,351 (183)

Nevirapine-induced side effects in pregnant women: experience of a brazilian university hospital

Brazilian Journal of Infectious Diseases
Nevirapine-based therapy is associated with increased frequency of adverse events among HIV-infected pregnant women. The aim of this article was to evaluate the incidence of adverse effects in HIV-infected women who started nevirapine during pregnancy. A
William Kondo, Elaine Aparecida Carraro, Elaine Prandel, Josiane Mourão Dias, Juliane Perini, Rodolfo Lara de Macedo, Taynah Cristina Cornelsen, Renato Sbalquiero, Maria das Graças Sasaki   +8 more
doaj   +1 more source

Immunovirological treatment out- comes after 2 years of antiretroviral therapy in children living with the human immune deficiency virus in Lagos Nigeria

Nigerian Journal of Paediatrics
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O, Akindele AJ, Akanmu AS, Adeyemi OO   +3 more
doaj  

Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials.

PLoS ONE, 2013
BackgroundNevirapine belongs to the group of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and is commonly administered in first-line treatment of HIV infection.ObjectiveSystematic review and meta-analysis was undertaken to compare ...
Paweł Kawalec, Joanna Kryst, Alicja Mikrut, Andrzej Pilc   +3 more
doaj   +1 more source

Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. [PDF]

, 2009
OBJECTIVES: To introduce the combined South African cohorts of the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) collaboration as reflecting the South African national antiretroviral treatment (ART) programme; to ...
Boulle, Andrew, Cornell, Morna, Davies, Mary-Ann, Eley, Brian, Fairall, Lara, Giddy, Janet, MacPhail, Patrick, Maxwell, Nicola, Mohapi, Lerato, Moultrie, Harry, Prozesky, Hans, Rabie, Helena, Technau, Karl, van Cutsem, Gilles, Wood, Robin   +14 more
core   +1 more source

Nevirapine-Induced Heratotoxicity: Incidence, Risk Factors and Associated Mortality in a Primary Care ART Programme in South Africa [PDF]

, 2009
CROI ...
Abrahams, M, Boulle, A, Chu, K, Ford, N, Goemaere, E, Hilderbrand, K, Mathee, S   +6 more
core   +1 more source

Incidence and determinants of nevirapine and efavirenz-related skin rashes in West Africans: nevirapine's epitaph?

PLoS ONE, 2014
Non-nucleoside reverse transcriptase inhibitor (NNRTI) associated rash is common and frequently leads to discontinuation of NNRTIs. This study assessed the risk of developing rashes and discontinuing NNRTIs and associated factors in a large clinic in ...
Fred Stephen Sarfo, Maame Anima Sarfo, Betty Norman, Richard Phillips, David Chadwick   +4 more
doaj   +1 more source

The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study. [PDF]

, 2020
BACKGROUND:Understanding factors driving virological failure, including the contribution of HIV drug resistance mutations (DRM), is critical to ensuring HIV treatment remains effective.
Barnhart, Scott, Gilmore, Hailey J, Grignon, Jessica S, Hunt, Gillian, Liegler, Teri, Lippman, Sheri A, Mooney, Alyssa C, Prach, Lisa M, Puren, Adrian, Truong, Hong-Ha M   +9 more
core  

Nevirapine Hepatotoxicity: Case Report and Discussion [PDF]

, 2012
Nevirapine (viramune) is a nonnucleoside reverse transcriptase inhibitor commonly used in combination with other antiretroviral medicines in the treatment of HIV/AIDS.
Baichi, Matt
core   +1 more source

Antiretroviral treatment outcomes in patients who received rifampicin together with nevirapine or efavirenz. [PDF]

, 2008
Cape Town TB ...
Boulle, A, Cohen, Karen, Goemaere, Eric
core   +1 more source

Discordant responses to antiretroviral treatment: prevalence, risk factors and associated mortality in Rwanda [PDF]

, 2008
Mexico AIDS Conference ...
Asiimwe, A, Rasschaert, F, van Griensven, Johan, Zachariah, R   +3 more
core   +1 more source